Tetraphase Pharmaceuticals Company Profile (NASDAQ:TTPH)

About Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals, Inc. (Tetraphase) is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. It is developing its lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a spectrum intravenous (IV) and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections. It has developed eravacycline using its chemistry technology. The Company's TP-271 is a fully synthetic spectrum preclinical compound that the Company developed for respiratory diseases caused by bacterial biothreat pathogens. The Company created TP-271 using its chemistry technology. In its development program for TP-271, the Company has conducted a number of in vitro, toxicology and animal studies to evaluate the efficacy of TP-271 against biothreat pathogens. It also develops TP-6076 for multidrug-resistant Gram- negative infections.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drugs - Generic
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: TTPH
CUSIP:

Key Metrics:

Previous Close: $3.85
50 Day Moving Average: $3.87
200 Day Moving Average: $4.29
52-Week Range: $3.12 - $12.45
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -1.78
P/E Growth: -0.01
Market Cap: $144.22M
Outstanding Shares: 36,698,000
Beta: 2.61

Profitability:

Net Margins: -821.25%
Return on Equity: -35.43%
Return on Assets: -33.62%

Debt:

Current Ratio: 18.04%
Quick Ratio: 18.04%

Additional Links:

Companies Related to Tetraphase Pharmaceuticals:

Consensus Ratings for Tetraphase Pharmaceuticals (NASDAQ:TTPH) (?)

Ratings Breakdown:	4 Hold Ratings, 1 Buy Rating
Consensus Rating:	Hold (Score: 2.20)
Consensus Price Target:	$10.00 (152.53% upside)

Analysts' Ratings History for Tetraphase Pharmaceuticals (NASDAQ:TTPH)

Show:

Date	Firm	Action	Rating	Price Target
8/5/2016	Wedbush	Reiterated Rating	Neutral	$4.00
5/16/2016	Gabelli	Reiterated Rating	Neutral
5/14/2016	Needham & Company LLC	Reiterated Rating	Hold
4/11/2016	BMO Capital Markets	Initiated Coverage	Market Perform	$8.00
11/19/2015	SunTrust Banks Inc.	Upgrade	Neutral -> Buy	$12.00 -> $21.00
9/9/2015	Guggenheim	Lower Price Target	Buy	$60.00 -> $20.00
9/9/2015	Robert W. Baird	Downgrade	Outperform -> Neutral	$41.00 -> $10.00
9/9/2015	Cantor Fitzgerald	Downgrade	Buy -> Hold	$50.00 -> $11.00
9/9/2015	Nomura	Downgrade	Buy -> Neutral	$54.00 -> $10.00
9/9/2015	Stifel Nicolaus	Downgrade	Buy -> Hold	$57.00
9/9/2015	Brean Capital	Downgrade	Buy -> Hold
9/9/2015	JMP Securities	Downgrade	Outperform -> Market Perform

(Data available from 9/27/2014 forward)

Earnings History for Tetraphase Pharmaceuticals (NASDAQ:TTPH)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/31/2016
8/4/2016	Q2	($0.46)	($0.47)	$2.05 million	$1.20 million	View	N/A
5/4/2016	Q1	($0.44)	($0.46)	$2.20 million	$2.00 million	View	N/A
2/23/2016	Q4	($0.44)	($0.50)	$3.23 million	$2.47 million	View	Listen
11/2/2015	Q315	($0.65)	($0.49)	$3.20 million	$2.90 million	View	N/A
8/5/2015	Q215	($0.62)	($0.72)	$2.73 million	$3.30 million	View	N/A
5/6/2015	Q115	($0.64)	($0.66)	$2.90 million	$3.00 million	View	N/A
3/5/2015		($0.54)	($0.69)			View	N/A
11/10/2014	Q314	($0.56)	($0.55)	$2.86 million	$2.29 million	View	N/A
8/12/2014	Q214	($0.54)	($0.71)	$2.79 million	$1.30 million	View	N/A
5/12/2014	Q114	($0.45)	($0.53)	$2.97 million	$2.50 million	View	N/A
3/6/2014		($0.46)	($0.49)			View	N/A
11/11/2013	Q3	($0.39)	($0.49)	$2.43 million	$2.20 million	View	N/A
5/13/2013	Q113	($0.27)	($0.30)	$2.49 million	$2.70 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Tetraphase Pharmaceuticals (NASDAQ:TTPH)

Current Year EPS Consensus Estimate: $-1.98 EPS
Next Year EPS Consensus Estimate: $-2.23 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	3	($0.46)	($0.41)	($0.44)
Q2 2016	2	($0.48)	($0.44)	($0.46)
Q3 2016	2	($0.49)	($0.47)	($0.48)
Q4 2016	2	($0.56)	($0.47)	($0.52)
Q1 2017	1	($0.56)	($0.56)	($0.56)
Q2 2017	1	($0.58)	($0.58)	($0.58)
Q3 2017	1	($0.59)	($0.59)	($0.59)
Q4 2017	1	($0.53)	($0.53)	($0.53)

(Data provided by Zacks Investment Research)

Dividend History for Tetraphase Pharmaceuticals (NASDAQ:TTPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Tetraphase Pharmaceuticals (NASDAQ:TTPH)

Insider Ownership Percentage: 4.40%
Institutional Ownership Percentage: 59.41%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/1/2015	Guy Macdonald	insider	Sell	10,000	$41.57	$415,700.00
8/14/2015	David Charles Lubner	CFO	Sell	9,500	$42.92	$407,740.00
8/13/2015	Patrick Taylor Horn	Insider	Sell	10,000	$44.69	$446,900.00
8/12/2015	L Patrick Gage	Director	Sell	15,000	$45.00	$675,000.00
7/20/2015	Guy Macdonald	Insider	Sell	15,000	$50.72	$760,800.00
7/14/2015	David Charles Lubner	CFO	Sell	7,500	$48.92	$366,900.00
7/13/2015	Patrick Taylor Horn	Insider	Sell	10,000	$48.93	$489,300.00
7/6/2015	John Craig Thompson	COO	Sell	10,000	$47.91	$479,100.00
7/1/2015	Guy Macdonald	Insider	Sell	10,000	$47.92	$479,200.00
6/15/2015	David Charles Lubner	CFO	Sell	17,500	$41.45	$725,375.00
6/15/2015	John Craig Thompson	COO	Sell	10,000	$41.51	$415,100.00
6/8/2015	John Craig Thompson	COO	Sell	22,499	$43.26	$973,306.74
6/1/2015	Guy Macdonald	Insider	Sell	16,087	$41.89	$673,884.43
5/11/2015	Guy Macdonald	Insider	Sell	20,000	$41.51	$830,200.00
1/20/2015	Guy Macdonald	Insider	Sell	34,135	$36.59	$1,248,999.65
10/2/2014	John Gordon Freund	Director	Sell	247,734	$20.88	$5,172,685.92
10/1/2014	John Gordon Freund	Director	Sell	142,146	$20.84	$2,962,322.64
9/30/2014	John Gordon Freund	Director	Sell	152,266	$20.18	$3,072,727.88
9/29/2014	John Gordon Freund	Director	Sell	95,648	$20.19	$1,931,133.12
9/23/2014	Guy Macdonald	Insider	Sell	10,000	$18.47	$184,700.00
9/17/2014	Guy Macdonald	Insider	Sell	10,000	$18.00	$180,000.00
9/17/2014	John Gordon Freund	Director	Sell	144,356	$17.21	$2,484,366.76
9/12/2014	John Gordon Freund	Director	Sell	55,644	$17.01	$946,504.44
9/8/2014	John Gordon Freund	Director	Sell	16,700	$15.01	$250,667.00
9/4/2014	John Gordon Freund	Director	Sell	183,300	$15.05	$2,758,665.00
9/3/2014	John Gordon Freund	Director	Sell	142,100	$15.04	$2,137,184.00
8/20/2014	Guy Macdonald	Insider	Sell	10,000	$11.59	$115,900.00
7/18/2014	Guy Macdonald	Insider	Sell	15,000	$10.61	$159,150.00
6/23/2014	John Gordon Freund	Director	Sell	47,184	$13.77	$649,723.68
6/20/2014	John Gordon Freund	Director	Sell	152,816	$13.39	$2,046,206.24
6/17/2014	David Charles Lubner	CFO	Sell	13,530	$12.51	$169,260.30
6/17/2014	Guy Macdonald	Insider	Sell	15,000	$12.28	$184,200.00
5/19/2014	Guy Macdonald	Insider	Sell	15,000	$9.00	$135,000.00
5/19/2014	Steven Ph.D. Gullans	Director	Buy	25,000	$9.24	$231,000.00
5/14/2014	L Patrick Gage	Director	Buy	5,000	$9.25	$46,250.00
4/14/2014	Guy Macdonald	Insider	Sell	15,000	$9.69	$145,350.00
3/20/2014	Joyce Sutcliffe	SVP	Sell	11,494	$12.41	$142,640.54
3/6/2014	David Charles Lubner	CFO	Sell	4,510	$13.65	$61,561.50
2/20/2014	Joyce Sutcliffe	SVP	Sell	11,494	$14.00	$160,916.00
2/12/2014	David Charles Lubner	CFO	Sell	4,506	$13.92	$62,723.52
2/7/2014	David Charles Lubner	CFO	Sell	9,928	$14.22	$141,176.16
2/5/2014	Joyce Sutcliffe	SVP	Sell	11,494	$13.93	$160,111.42
9/18/2013	Ventures Vi Lp Cmea	major shareholder	Sell	100,000	$10.20	$1,020,000.00
9/17/2013	Ventures Vi Lp Cmea	major shareholder	Sell	53,468	$9.26	$495,113.68
3/25/2013	John Gordon Freund	Director	Buy	681,012	$7.00	$4,767,084.00
3/25/2013	Medical Fund Lp Excel	Major Shareholder	Buy	496,121	$7.00	$3,472,847.00
3/20/2013	Fmr Llc	Insider	Buy	642,857	$7.00	$4,499,999.00

(Data available from 1/1/2013 forward)

Latest Headlines for Tetraphase Pharmaceuticals (NASDAQ:TTPH)

Date	Headline
	Analyst Consensus Estimates & Projections are in For Shares of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Frisco Fastball (NASDAQ:TTPH) friscofastball.com - September 13 at 8:50 AM
	ETF’s with exposure to Tetraphase Pharmaceuticals, Inc. : September 7, 2016 (NASDAQ:TTPH) www.capitalcube.com - September 7 at 11:40 AM
	ETF’s with exposure to Tetraphase Pharmaceuticals, Inc. : August 25, 2016 (NASDAQ:TTPH) www.capitalcube.com - August 25 at 8:12 PM
	Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Company In Focus: Analysts & Crowd Weigh in - Post News (NASDAQ:TTPH) www.kentuckypostnews.com - August 24 at 7:40 PM
	Stock Tracking Lower for the Quarter: Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Post News (NASDAQ:TTPH) www.kentuckypostnews.com - August 20 at 7:27 PM
	Is it Time to Buy Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)? Crowd & Analysts Weigh in - Post News (NASDAQ:TTPH) www.kentuckypostnews.com - August 17 at 8:15 PM
	Will Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Surprise This Quarter? - Investor Newswire (NASDAQ:TTPH) www.investornewswire.com - August 14 at 8:36 AM
	TETRAPHASE PHARMACEUTICALS INC Financials (NASDAQ:TTPH) finance.yahoo.com - August 12 at 8:04 PM
	Tetraphase Pharmaceuticals, Inc. :TTPH-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:TTPH) www.capitalcube.com - August 12 at 11:11 AM
	Tetraphase Pharmaceuticals to Present at 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:TTPH) globenewswire.com - August 8 at 8:37 AM
	Tetraphase Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Progress (NASDAQ:TTPH) www.stockhouse.com - August 5 at 8:10 PM
	Tetraphase reports 2Q loss (NASDAQ:TTPH) sg.finance.yahoo.com - August 5 at 11:00 AM
	Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Updated Price ... - FTSE News (NASDAQ:TTPH) www.ftsenews.co.uk - August 4 at 11:12 AM
	Tetraphase Pharma (TTPH) Commences Dosing in TP-6076 Phase ... - StreetInsider.com (NASDAQ:TTPH) www.streetinsider.com - August 2 at 8:53 AM
	Top Earnings to Watch for: Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - The Voice Registrar (NASDAQ:TTPH) voiceregistrar.com - August 2 at 8:53 AM
	8:02 am Tetraphase Pharmaceuticals initiates patient dosing in a phase 1 clinical trial for intravenous TP-6076 (NASDAQ:TTPH) finance.yahoo.com - August 1 at 8:02 AM
	Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-6076, a Second-Generation Antibiotic Candidate Highly Active Against MDR Bacteria (NASDAQ:TTPH) finance.yahoo.com - August 1 at 8:00 AM
	Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - July 23 at 11:44 AM
	Tetraphase Pharmaceuticals Incorporated (NASDAQ:TTPH) Sellers Covered 19.37% of Their Shorts - Consumer Eagle (NASDAQ:TTPH) www.consumereagle.com - July 23 at 11:44 AM
	Tetraphase Pharmaceuticals Inc. (TTPH) Drops 5.73% on July 19 - Equities.com (NASDAQ:TTPH) www.equities.com - July 20 at 9:00 PM
	Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:TTPH) telanaganapress.com - July 13 at 10:49 AM
	How Analysts Rated Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) Last Week? - Consumer Eagle (NASDAQ:TTPH) www.consumereagle.com - July 13 at 10:49 AM
	Stock Rating Watch and Earnings Insight for Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Press Telegraph (NASDAQ:TTPH) presstelegraph.com - July 11 at 8:55 AM
	Tetraphase Pharmaceuticals Incorporated (NASDAQ:TTPH) Short Interest Decreased By 11.01% - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - July 8 at 10:47 AM
	Can Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - July 8 at 10:47 AM
	Company Stock Focus for Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH): Which Way Will Shares Head? - Press Telegraph (NASDAQ:TTPH) presstelegraph.com - July 8 at 10:47 AM
	Heightened Volatility Check on: Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - July 7 at 8:02 PM
	Share Performance Recap for: Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Press Telegraph (NASDAQ:TTPH) presstelegraph.com - July 4 at 6:54 PM
	Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - July 1 at 10:35 AM
	Are Analysts Bullish Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) After Last Week? - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - June 30 at 8:05 PM
	Stock under Analysts' radar: Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - News Oracle (NASDAQ:TTPH) www.newsoracle.com - June 30 at 8:05 PM
	Tetraphase Pharmaceuticals : Added to the Russell Microcap Index (NASDAQ:TTPH) www.4-traders.com - June 29 at 7:51 PM
	Tetraphase Pharmaceuticals Added to the Russell Microcap® Index - GlobeNewswire (press release) (NASDAQ:TTPH) globenewswire.com - June 28 at 7:50 PM
	Check on Share Volatility: Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - June 28 at 7:50 PM
	Tetraphase Pharmaceuticals Incorporated (NASDAQ:TTPH) Sellers Covered 11.01% of Their Shorts - Engelwood Daily (NASDAQ:TTPH) www.engelwooddaily.com - June 28 at 7:50 PM
	Tetraphase Pharmaceuticals Added to the Russell Microcap® Index (NASDAQ:TTPH) www.publicnow.com - June 28 at 9:51 AM
	Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Updated Price Targets - FTSE News (NASDAQ:TTPH) www.ftsenews.co.uk - June 28 at 8:41 AM
	Share Update and Earnings Review for Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Press Telegraph (NASDAQ:TTPH) presstelegraph.com - June 27 at 8:25 AM
	Next Weeks Broker Price Targets For Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) - Fiscal Standard (NASDAQ:TTPH) www.fiscalstandard.com - June 27 at 8:25 AM
	Covering the Bases on Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH): Where is the Stock Going? - Press Telegraph (NASDAQ:TTPH) presstelegraph.com - June 26 at 8:34 AM
	Hynes Keller & Hernandez, LLC Announces Investigation of Tetraphase Pharmaceuticals Inc. (TTPH) - PR Newswire (press release) (NASDAQ:TTPH) www.prnewswire.com - June 23 at 8:42 PM
	Hynes Keller & Hernandez, LLC Announces Investigation of Tetraphase Pharmaceuticals Inc. (TTPH) (NASDAQ:TTPH) finance.yahoo.com - June 23 at 1:16 PM
	Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Stock Momentum Hits EXTREME Weakness - CML News (NASDAQ:TTPH) news.cmlviz.com - June 23 at 10:29 AM
	Tetraphase Pharmaceuticals : Presents Antibiotics Pipeline Data at ASM Microbe 2016 (NASDAQ:TTPH) www.4-traders.com - June 21 at 7:26 PM
	Tetraphase Pharma (TTPH) Presents Data from IGNITE1 and IGNITE2 at ASM Conference (NASDAQ:TTPH) www.streetinsider.com - June 21 at 8:37 AM
	Tetraphase Pharma (TTPH) Presents Data from IGNITE1 and IGNITE2 at ASM Conference - StreetInsider.com (NASDAQ:TTPH) www.streetinsider.com - June 20 at 7:29 PM
	Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data at ASM Microbe 2016 (NASDAQ:TTPH) www.publicnow.com - June 20 at 4:29 PM
	Tetraphase Pharmaceuticals Inc. (TTPH) Jumps 5.01% on June 16 - Equities.com (NASDAQ:TTPH) www.equities.com - June 16 at 8:06 PM
	Tetraphase Pharmaceuticals to Present at 2016 JMP Securities Life Sciences Conference (NASDAQ:TTPH) www.publicnow.com - June 15 at 8:19 AM
	TETRAPHASE PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:TTPH) biz.yahoo.com - June 14 at 4:13 PM